10/15/24 09:21 | 10/11/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 200 | 13.80 | 0 | 15 | 7 | 216 | D | | | | | | | | | | | | | | |
8/7/24 10:17 | 8/6/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 51 | 16.86 | 0 | 3 | 15 | 23 | D | | | | | | | | | | | | | | |
4/17/24 12:04 | 4/17/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 124 | 12.36 | 0 | 10 | 28 | 46 | D | | | | | | | | | | | | | | |
4/11/24 11:40 | 4/11/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | P | 98 | 13.06 | 0 | 8 | 54 | 21 | D | | | | | | | | | | | | | | |
4/10/24 16:18 | 4/10/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 156 | 12.51 | 0 | 13 | 71 | 30 | D | | | | | | | | | | | | | | |
4/10/24 14:25 | 4/10/24 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 284 | 12.36 | 0 | 23 | 18 | 152 | D | | | | | | | | | | | | | | |
11/3/23 13:59 | 11/3/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | P | 32 | 16.06 | 0 | 2 | 8 | 27 | D | | | | | | | | | | | | | | |
10/26/23 08:01 | 10/25/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 152 | 15.17 | 0 | 10 | 38 | 36 | D | | | | | | | | | | | | | | |
10/12/23 16:01 | 10/12/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 46 | 15.19 | 0 | 3 | 17 | 20 | D | | | | | | | | | | | | | | |
10/11/23 16:21 | 10/11/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 150 | 15.03 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
1/18/23 17:04 | 1/13/23 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 45 | 17.91 | 0 | 3 | 27 | 12 | D | | | | | | | | | | | | | | |
10/11/22 19:09 | 10/11/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Quinlan Steven J. | MI | O | VP,CFO | P | 58 | 11.63 | 0 | 5 | 18 | 33 | D | | | | | | | | | | | | | | |
10/4/22 18:43 | 10/3/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | P | 28 | 13.89 | 0 | 2 | 9 | 23 | D | | | | | | | | | | | | | | |
9/28/22 17:29 | 9/28/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 100 | 14.31 | 0 | 7 | 254 | 10 | D | | | | | | | | | | | | | | |
9/28/22 17:27 | 9/28/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | P | 316 | 14.37 | 0 | 22 | 38 | 80 | D | | | | | | | | | | | | | | |
8/17/22 20:15 | 8/16/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Vetter Darci L | MI | D | | P | 24 | 21.83 | 0 | 1 | 387 | 1 | D | | | | | | | | | | | | | | |
8/10/22 14:27 | 7/27/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | P | 148 | 22.70 | 0 | 7 | 123 | 12 | D | | | | | | | | | | | | | | |
8/4/22 19:03 | 8/2/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Green Ronald D | MI | D | | P | 34 | 22.50 | 0 | 2 | 16 | 11 | D | | | | | | | | | | | | | | |
8/2/22 14:28 | 7/29/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | P | 404 | 23.07 | 0 | 18 | 43 | 58 | D | | | | | | | | | | | | | | |
7/28/22 13:04 | 7/27/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 46 | 22.98 | 0 | 2 | 17 | 14 | D | | | | | | | | | | | | | | |
1/28/22 18:43 | 1/25/22 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | Chief Co | P | 50 | 35.78 | 0 | 1 | 146 | 2 | D | | | | | | | | | | | | | | |
9/24/21 17:49 | 9/23/21 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 43 | 42.92 | 0 | 1 | 9 | 12 | D | | | | | | | | | | | | | | |
3/27/20 18:12 | 3/25/20 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | DO | P,CEO | P | 102 | 58.24 | 0 | 2 | 12 | 16 | D | | | | | | | | | | | | | | |
3/27/20 18:08 | 1/8/20 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | DO | P,CEO | P | 99 | 65.40 | 0 | 2 | 12 | 14 | D | | | | | | | | | | | | | | |
3/27/20 17:58 | 3/26/20 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 44 | 60.62 | 0 | 1 | 15 | 6 | D | | | | | | | | | | | | | | |
9/28/18 20:56 | 9/26/18 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | O | P,CEO | P | 316 | 73.58 | 0 | 4 | New | 4 | D | | | | | | | | | | | | | | |
9/28/18 20:34 | 9/26/18 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 37 | 73.37 | 0 | 1 | 12 | 5 | D | | | | | | | | | | | | | | |
7/31/17 14:41 | 7/27/17 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 32 | 64.64 | 0 | 1 | 19 | 3 | D | | | | | | | | | | | | | | |
3/29/16 18:44 | 3/24/16 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Quinlan Steven J. | MI | O | VP,CFO | P | 100 | 44.73 | 10 | 2 | 28 | 10 | D | -1 | -6 | -7 | -23 | -5 | -15 | -10 | -14 | 2 | -1 | -2 | 8 | 22 | 36 |
2/1/16 08:07 | 1/28/16 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Parnell Jack C | | D | | P | 1 | 50.25 | 10 | 0 | 0 | 23 | D | 24 | 8 | -8 | -3 | -11 | -2 | 0 | 0 | 2 | -5 | -3 | -9 | 6 | 24 |
9/24/15 18:13 | 9/22/15 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Quinlan Steven J. | MI | O | VP,CFO | P | 50 | 47.17 | 10 | 1 | 16 | 8 | D | 21 | 20 | -1 | 0 | -16 | -7 | -10 | -11 | 1 | -7 | 0 | 17 | -8 | 22 |
9/24/15 18:00 | 9/22/15 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Reed Thomas H | | D | | P | 191 | 47.80 | 10 | 4 | 354 | 5 | D | 21 | 20 | -1 | 0 | -16 | -7 | -10 | -11 | 1 | -7 | 0 | 17 | -8 | 22 |
8/5/15 16:19 | 8/3/15 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Yeutter Clayton K | | D | | P | 29 | 58.32 | 15 | 1 | New | 1 | D | 50 | 32 | 21 | 34 | 17 | 18 | 0 | 1 | -1 | -3 | -11 | -5 | -12 | -5 |
4/21/15 14:02 | 4/20/15 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Calk Richard E Jr | MI | O | P,COO | P | 249 | 45.84 | 8 | 5 | New | 5 | D | 41 | 9 | 10 | -5 | -7 | -3 | -2 | -3 | 4 | 0 | -1 | 5 | 6 | 3 |
7/28/14 14:41 | 7/24/14 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Quinlan Steven J. | MI | O | VP,CFO | P | 40 | 42.96 | 10 | 1 | 16 | 7 | D | 49 | 9 | -1 | 1 | 14 | 0 | 5 | 13 | 5 | 3 | 1 | 2 | 17 | 41 |
10/19/12 17:35 | 10/18/12 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Fischer A. Charles | MI | D | | P | 42 | 42.49 | 9 | 1 | 50 | 3 | D | 21 | 17 | 11 | -2 | 7 | -1 | 0 | -1 | 2 | 3 | 5 | 12 | 21 | 65 |
5/21/12 17:38 | 5/21/12 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Yeutter Clayton K | | D | | P | 10 | 39.00 | 5 | 0 | 3 | 8 | I | 56 | -10 | 1 | 9 | 3 | -1 | 0 | 0 | -2 | -2 | 12 | 4 | 10 | 40 |
1/3/12 13:06 | 12/27/11 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Yeutter Clayton K | | D | | P | 114 | 30.92 | 11 | 4 | 102 | 7 | I | 30 | -25 | -32 | -12 | -17 | -14 | -7 | -1 | 3 | 0 | 10 | 30 | 55 | 49 |
12/30/11 10:42 | 12/27/11 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Quinlan Steven J. | MI | O | VP,CFO | P | 100 | 31.12 | 11 | 3 | 496 | 4 | I | 27 | -27 | -32 | -11 | -20 | -10 | -8 | -1 | 0 | 0 | 6 | 27 | 50 | 49 |
12/28/11 11:03 | 12/23/11 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Fischer A. Charles | MI | D | | P | 31 | 30.91 | 12 | 1 | 100 | 2 | D | 27 | -26 | -31 | -6 | -20 | -14 | -10 | -4 | -3 | 0 | 5 | 28 | 48 | 44 |
10/13/11 17:30 | 10/11/11 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Yeutter Clayton K | | D | | P | 5 | 34.87 | 11 | 0 | 4 | 4 | I | 78 | 4 | -7 | -21 | 6 | 8 | 14 | 9 | 1 | -3 | 1 | -17 | 0 | 14 |
8/24/11 17:49 | 8/23/11 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | P.d | 18 | 35.06 | 9 | 1 | 100 | 1 | D | 78 | 24 | -5 | -15 | -26 | -11 | -5 | 2 | -3 | 0 | -3 | 2 | 0 | 16 |
8/16/11 19:00 | 8/12/11 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Yeutter Clayton K | | D | | P.m | 36 | 36.47 | 9 | 1 | 29 | 4 | I | 101 | 34 | -4 | -8 | -19 | -13 | 1 | 8 | 1 | -11 | -9 | 8 | -5 | 6 |
8/16/11 18:35 | 8/4/11 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowder Richard T | | D | | P | 19 | 38.11 | 9 | 1 | 100 | 1 | D | 101 | 34 | -4 | -8 | -19 | -13 | 1 | 8 | 1 | -11 | -9 | 8 | -5 | 6 |
8/4/11 17:02 | 8/4/11 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Quinlan Steven J. | MI | O | VP,CFO | P | 19 | 37.19 | 7 | 1 | New | 1 | D | 98 | 30 | 5 | 0 | -8 | -16 | -15 | -6 | 0 | -6 | -5 | 0 | -9 | 3 |
8/3/11 13:44 | 8/1/11 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Yeutter Clayton K | | D | | P | 13 | 41.98 | 7 | 0 | 9 | 3 | I | 96 | 29 | 3 | -4 | -10 | -19 | -19 | -5 | 2 | -1 | -9 | 1 | -12 | 0 |
8/2/11 18:14 | 8/1/11 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Fischer A. Charles | MI | D | | P | 40 | 39.97 | 7 | 1 | New | 1 | D | 106 | 35 | 11 | -4 | -4 | -14 | -14 | 1 | 2 | -6 | -8 | 3 | -14 | 1 |
10/5/10 10:47 | 10/1/10 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Crowder Richard T | | D | | P.d | 16 | 32.75 | 5 | 1 | New | 1 | D | 84 | 58 | 29 | 30 | 16 | 4 | 3 | -3 | 3 | 4 | 6 | 28 | 27 | -3 |
11/19/09 11:31 | 11/17/09 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Yeutter Clayton K | | D | | P.d | 7 | 33.01 | 4 | 0 | 11 | 2 | I | 34 | 42 | 56 | 16 | 10 | 6 | 4 | 8 | -2 | -2 | 2 | 4 | 12 | 60 |
5/5/09 17:58 | 5/4/09 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Yeutter Clayton K | | D | | P.am | 20 | 22.20 | 5 | 1 | 90 | 2 | I | 30 | -14 | -25 | -16 | 9 | 3 | -1 | -6 | 0 | 1 | 11 | 33 | 45 | 79 |
5/5/09 17:42 | 5/4/09 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Yeutter Clayton K | | D | | P.m | 20 | 22.20 | 5 | 1 | New | 1 | I | 30 | -14 | -25 | -16 | 9 | 3 | -1 | -6 | 0 | 1 | 11 | 33 | 45 | 79 |
1/9/09 10:34 | 1/8/08 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Kodilla Kenneth V | MI | O | VP | P | 14 | 24.71 | 4 | 1 | 22 | 3 | | | | | | | | | | -1 | -5 | 8 | -11 | 14 | 44 |
11/21/08 14:24 | 11/21/08 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Mozola Mark A | | O | VP | P | 22 | 21.78 | 7 | 1 | 25 | 5 | D | 62 | -16 | -15 | -18 | -12 | -26 | -18 | -12 | -4 | 4 | 9 | 3 | 1 | 52 |
7/28/08 17:47 | 7/25/08 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Yeutter Clayton K | | D | | P | 26 | 25.90 | 7 | 1 | New | 1 | I | 101 | 39 | 12 | 6 | 2 | 15 | 10 | 3 | 5 | 4 | -2 | 11 | -8 | 12 |
2/21/08 10:30 | 10/5/07 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Kodilla Kenneth V | MI | O | VP | P.m | 45 | 24.00 | 2 | 2 | 258 | 3 | D | 80 | 79 | 32 | 2 | 0 | 13 | 7 | 0 | 5 | 7 | -4 | -3 | 2 | -5 |
11/20/07 20:50 | 11/19/07 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Current Richard R | | O | VP,CFO | P | 3 | 25.91 | 3 | 0 | 0 | 48 | D | 94 | 85 | 41 | 25 | 1 | -4 | -6 | -8 | -1 | 4 | -2 | 6 | -5 | -10 |
1/11/06 15:01 | 1/9/06 | NEOG | Health | Diagn | In Vitro & In Vivo Diagnostic | Current Richard R | | O | VP CFO | P | 2 | 20.45 | 2 | 0 | 0 | 22 | | | | | | | | | | 0 | -2 | 0 | 5 | -19 | -5 |